Page tree
Skip to end of metadata
Go to start of metadata

Current page needs more text

We started, but this page is not yet finished. Add what you think is missing!



Ovarian cancer can be highly resistant to chemotherapy. Epigenetic CRISPR techniques would allow elements of the genome to be "unblocked" so that they become susceptible to chemotherapy again. © 2016

Desktop Genetics and Imperial College "Epigenetic CRISPR -omics" Project 


Additional Infos

Latest news







What do you think?

About the author

View full profile Edward Perello from London

Edward Perello is the founder of Desktop Genetics, a company at the forefront of CRISPR genome editing technology. His team is working to provide researchers with access to state of the art genome engineering capabilities from their computers and create an AI that can predict optimal genome editing solutions in any organism.

Edward is a SynBio LEAP fellow working to get more non-biologists into the field.